-
2023-504547-14-01
Reversible cerebral vasoconstriction syndrome
-
2023-509259-15-01
Polycystic ovary syndrome
-
2023-509659-15-00
Patients with ovarian cancer, fallopian tube cancer, pe
-
2023-510312-40-00
Secondary hyperparathyroidism
-
2024-511585-36-00
pediatric kidney transplant recipients
-
2024-512350-17-01
Patients with coronary artery disease and an indication
-
2024-513799-16-00
Acute Heart Failure
-
2024-515046-17-00
Heart Failure
-
2024-515140-23-00
Hand eczema
-
2024-515306-61-00
Adults diagnosed with lower limbs erysipelas
-
2024-515462-14-00
Long term potential effect of repeated exposure to eith
-
2024-515545-41-00
a prospective, case-controlled study
-
2024-515676-12-00
Bullous pemphigoid
-
2024-515820-35-02
Patients have peristent peripheral neuropathic pain. Th
-
2024-516097-30-00
Community acquired pneumonia (CAP)
-
2024-516144-25-00
intermediate-high risk acute pulmonary embolism
-
2024-516228-33-00
Type 2 Diabetes
-
2024-516415-24-03
General anesthesia
-
2024-516718-39-00
Melanoma
-
2024-516723-14-00
Rheumatoid Arthritis
-
2024-517149-15-00
Rectal cancer
-
2024-517211-79-00
Antifungal prophylaxis in patients with acute myeloid l
-
2024-517233-40-00
Perianal abscess
-
2024-517759-11-00
Inflammatory Bowel Disease